Skip to Content
About Us Become an Authorised Buyer Medical Partners Blog Contact Us
🌐Ship toSelect country
  1. All products
  2. Shop by Brand
  3. Restylane Lyft Lidocaine - 1 x 1,0ml
  4. Shop by Brand
Pricelist: Default Pricelist
Pricelist: Default Pricelist
Restylane Lyft Lidocaine - 1 x 1,0ml

Restylane Lyft Lidocaine - 1 x 1,0ml

Restylane Lyft is a Galderma hyaluronic acid filler built on firm NASHA technology, providing the range's greatest structural support. It is FDA-approved for correction of deep creases and folds in the cheeks, mid-face contour restoration, and is also FDA-approved for volumising the back of the hands. For use by licensed, trained medical professionals only.

FDA-Approved
76.00 € 76.00 €
  • Brand
Contact Us
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand Restylane®
SKU A0206 Share
Treatment Areas CheeksChinMouthNasolabial folds
Tags FDA-Approved

Restylane Lyft is a firmer, larger-particle hyaluronic acid filler from Galderma, built on NASHA technology, designed for facial volumising and contouring in areas such as the cheeks. Formulated with lidocaine for a more comfortable injection experience; also indicated for hand volume restoration.

CONCENTRATION

  • Hyaluronic acid (NASHA technology, large particle)
  • Lidocaine hydrochloride 0.3%

THE PACK INCLUDES

  • 1 x 1.0ml Syringe

STORAGE CONDITIONS

  • Store between 2°C and 25°C

RESULTS & DURATION

Results typically last 12-18 months, depending on individual metabolism and treatment area.

INDICATIONS

  • Loss of cheek and mid-face volume
  • Hand volume loss

TREATMENT AREAS

  • Cheeks
  • Hands
  • Face, general

Restylane Lyft is injected into the deep dermis or subcutaneous plane using bolus or fanning technique.

Results are visible immediately, with final results assessed after 2-4 weeks.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid or lidocaine
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin